These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 34009698)

  • 21. Lactobacillus paraplantarum THG-G10 as a potential anti-acne agent with anti-bacterial and anti-inflammatory activities.
    Cha H; Kim SK; Kook M; Yi TH
    Anaerobe; 2020 Aug; 64():102243. PubMed ID: 32712375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. INDIVIDUAL ARTICLE: Antibiotic Stewardship in Acne: 2023 Update.
    Issa NT; Kircik LH
    J Drugs Dermatol; 2024 Feb; 23(2):SF37896s4-SF378969s10. PubMed ID: 38306149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
    J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris.
    O'Neill AM; Gallo RL
    Microbiome; 2018 Oct; 6(1):177. PubMed ID: 30285861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of acne.
    Toyoda M; Morohashi M
    Med Electron Microsc; 2001 Mar; 34(1):29-40. PubMed ID: 11479771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
    Nishijima S; Kurokawa I; Katoh N; Watanabe K
    J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sarecycline inhibits protein translation in Cutibacterium acnes 70S ribosome using a two-site mechanism.
    Lomakin IB; Devarkar SC; Patel S; Grada A; Bunick CG
    Nucleic Acids Res; 2023 Apr; 51(6):2915-2930. PubMed ID: 36864821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical phage therapy in a mouse model of Cutibacterium acnes-induced acne-like lesions.
    Rimon A; Rakov C; Lerer V; Sheffer-Levi S; Oren SA; Shlomov T; Shasha L; Lubin R; Zubeidat K; Jaber N; Mujahed M; Wilensky A; Coppenhagen-Glazer S; Molho-Pessach V; Hazan R
    Nat Commun; 2023 Feb; 14(1):1005. PubMed ID: 36813793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial Susceptibility of
    Solís MB; Zurita J; Velasco N; Dressendorfer LM
    Skinmed; 2018; 16(3):159-165. PubMed ID: 29989535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel pharmacological approaches for the treatment of acne vulgaris.
    Valente Duarte de Sousa IC
    Expert Opin Investig Drugs; 2014 Oct; 23(10):1389-410. PubMed ID: 24890096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acne, the Skin Microbiome, and Antibiotic Treatment.
    Xu H; Li H
    Am J Clin Dermatol; 2019 Jun; 20(3):335-344. PubMed ID: 30632097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance.
    Leyden JJ; Del Rosso JQ; Webster GF
    Cutis; 2007 Jun; 79(6 Suppl):9-25. PubMed ID: 17649854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding the role of Propionibacterium acnes in acne vulgaris: The critical importance of skin sampling methodologies.
    Omer H; McDowell A; Alexeyev OA
    Clin Dermatol; 2017; 35(2):118-129. PubMed ID: 28274348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acne and diet: a review of pathogenic mechanisms.
    González-Mondragón EA; Ganoza-Granados LDC; Toledo-Bahena ME; Valencia-Herrera AM; Duarte-Abdala MR; Camargo-Sánchez KA; Mena-Cedillos CA
    Bol Med Hosp Infant Mex; 2022; 79(2):83-90. PubMed ID: 35468121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are antibiotics still relevant in acne? A review of the therapeutic conundrum.
    Monteiro RC; Fernandes M
    Int J Dermatol; 2024 Mar; 63(3):306-310. PubMed ID: 37743606
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Bronnec V; Eilers H; Jahns AC; Omer H; Alexeyev OA
    Front Cell Infect Microbiol; 2021; 11():809792. PubMed ID: 35155271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study.
    Abdel Fattah NS; Darwish YW
    J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1546-51. PubMed ID: 23279041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action.
    Pollock B; Turner D; Stringer MR; Bojar RA; Goulden V; Stables GI; Cunliffe WJ
    Br J Dermatol; 2004 Sep; 151(3):616-22. PubMed ID: 15377348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of acne vulgaris: recent advances.
    Bhambri S; Del Rosso JQ; Bhambri A
    J Drugs Dermatol; 2009 Jul; 8(7):615-8. PubMed ID: 19588637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic resistance in the topical treatment of acne vulgaris.
    Leyden JJ
    Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.